ALB and acute kidney injury: Although there is potential evidence that use of intravenous albumin may reduce the risk of AKI in particular patient population, such as off-pump coronary artery bypass surgery (CABG) patients [50], it is unclear if normalization of admission serum albumin can reduce the risk of in-hospital AKI among general hospitalized patients.